In this issue:
Cancer risk can be moderated by reducing alcohol consumption
ctDNA to guide panitumumab rechallenge in metastatic CRC
Alcohol consumption increases risk of CRC, independent of genetic risk
Detecting proximal serrated polyps mitigates risk of post-colonoscopy CRC
Organ preservation possible in half of patients with rectal cancer who receive TNT
HRQoL after neoadjuvant CRT for rectal cancer
Re-evaluating RAPIDO findings regarding TNT for LARC
Immunotherapy for PD-L1 positive early-stage gastroesophageal cancer
PD-L1 inhibition plus lenvatinib for advanced gallbladder cancer
Risk factors for metachronous peritoneal carcinomatosis
Please login below to download this issue (PDF)